Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations. - Wikidata - wikimedia - TriplyDB

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.

http://www.wikidata.org/entity/Q33360753

about

Biopsy versus partial versus gross total resection in older patients with high-grade glioma: a systematic review and meta-analysis Temozolomide: a milestone in neuro-oncology and beyond?[Adjuvant radiochemotherapy in the elderly affected by glioblastoma: single-institution experience and literature review].Radiation therapy for older patients with brain tumors Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas.Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: a pooled data analysis of three prospective mono-institutional phase II studies.Management of elderly patients with gliomas Towards personalized therapy for patients with glioblastoma.New developments in the treatment of malignant gliomas.Management of glioblastoma.Malignant astrocytomas of elderly patients lack favorable molecular markers: an analysis of the NOA-08 study collective Palliative treatment of poor prognosis patients with malignant gliomas.Optimizing radiotherapy schedules for elderly glioblastoma multiforme patients.Outcomes in newly diagnosed elderly glioblastoma patients after concomitant temozolomide administration and hypofractionated radiotherapy.Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma.High-grade glioma in elderly patients: can the oncogeriatrician help?Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.Hypofractionated radiotherapy with or without concurrent temozolomide in elderly patients with glioblastoma multiforme: a review of ten-year single institutional experience.Elderly patients with glioblastoma: the treatment challenge.Treatment of malignant gliomas in elderly patients: a concise overview of the literature.Treating glioblastoma patients with poor performance status: where do we go from here?Treating glioblastoma in the elderly.Radiation therapy for older adults with glioblastoma: radical treatment, palliative treatment, or no treatment at all?The future of glioblastoma therapy: synergism of standard of care and immunotherapy.Glioblastoma care in the elderly.Temozolomide-mediated radiosensitization of human glioma cells in a zebrafish embryonic system.Abbreviated course of radiation therapy with concurrent temozolomide for high-grade glioma in patients of advanced age or poor functional status.Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival.Radiotherapy with and without temozolomide in elderly patients with glioblastoma.Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide.Up-front temozolomide in elderly patients with anaplastic oligodendroglioma and oligoastrocytoma.SEOM guideline for the treatment of malignant glioma.A meta-analysis of temozolomide versus radiotherapy in elderly glioblastoma patients.Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort study.Primary brain tumors in the elderly population.Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.Radiotherapy with Concurrent and Adjuvant Temozolomide: A New Standard of Care for Glioblastoma Multiforme

P2860

Q28088458-DA0CBBED-536D-4456-B4F0-5A9EC42CC588 Q33372340-6B1C6EC3-B1A4-45C2-AD95-02B06497E377 Q33404566-FC47FB9E-D5DC-4A99-BCD6-A68BE5936271 Q33815025-57C4ECF0-A8F8-48BE-B6A3-B1B1024FAE01 Q33973844-08410770-8A64-48E3-A564-7A26A94F5539 Q34295064-89F0D4D8-55A8-4495-98D5-D541D2E4399B Q34641001-B8C6A7D2-2266-49D9-A4BF-33CC0217601D Q34978252-92570DC7-1701-42FE-99A0-3D986BAB0B12 Q36972696-039ECBEB-5F6F-4E83-AB70-593405370DA4 Q37013025-B3B7F6CF-8873-42DB-A1E3-84E1AF37EEB8 Q37021557-58352927-2A72-4EFB-B96C-F50963DA47D6 Q37038922-FCAA662C-96C0-4DFD-888A-8A7DC36C47C7 Q37159513-703DD618-3B13-4DF2-82C0-0B07A97093F0 Q37226536-C4F40832-DC2D-482F-9CE5-A5715EA6FFF6 Q37237358-88455E46-9652-4BEC-8D60-0A3D9549B5E5 Q37388217-291AC40C-FAC5-4169-86CF-69C7FF16F76A Q37628704-4AD06FFD-D9E1-4C40-9DBB-C3ECD22E9A89 Q37959367-CEB2008D-8A1B-4E16-8682-6D6026595781 Q38151772-EDA8C7AA-8AB1-4DA1-9357-8C999A4809E9 Q38215192-8353C5C4-6E73-4DFA-A12C-3B80FC41030A Q38233183-EE0F2F76-CDB4-462F-973D-341B571CC080 Q38233427-45A512A5-E741-48E0-A104-520DDBA1089D Q38237311-9958097C-1674-4865-AC79-31ACA383EA58 Q38255481-436AF220-3539-4F3D-95B3-61838F1AB52A Q38653138-8C6F37CF-5D88-4B64-AA46-DD4A1FEB81B6 Q39583530-06AA0B3A-331B-4565-BD94-CF8BBC86FEAB Q43542819-C3A335F9-263D-43A8-8F41-453EA7E2FD1A Q43952711-EE4ED237-02E8-47D3-B819-C665E331E3F5 Q44220822-6DF96297-7748-4EF2-B3A7-F3E5B951BEC5 Q48099567-76C27B23-0942-4567-8BBE-422E9593B7B4 Q48161996-D7F9F1B1-5227-42BB-B6B8-5664782A7010 Q48464940-DD20B084-EBE7-46E5-BCDE-1C4AE89ECDB7 Q48901436-057FFE8B-7259-463D-8235-EE59B19188E1 Q48905126-B0026511-B876-4A51-9E9F-2CC9975D2BEE Q53083081-A9579048-871C-4E1A-B5CC-1C26AEEA83A4 Q55460926-FC4ABEA4-D627-4628-A790-369DA2339272 Q55461155-994308A5-CC29-4B13-A65E-C3D64AE3A46D Q56453569-40869CEE-56FB-4ABA-91F2-DF5F436D69C6

P2860

Phase II study of temozolomide without radiotherapy in newly diagnosed glioblastoma multiforme in an elderly populations.

http://www.wikidata.org/entity/Q33360753

description

2004 nî lūn-bûn

@nan

2004 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Phase II study of temozolomide ...... rme in an elderly populations.

@ast

Phase II study of temozolomide ...... rme in an elderly populations.

@en

type

label

Phase II study of temozolomide ...... rme in an elderly populations.

@ast

Phase II study of temozolomide ...... rme in an elderly populations.

@en

prefLabel

Phase II study of temozolomide ...... rme in an elderly populations.

@ast

Phase II study of temozolomide ...... rme in an elderly populations.

@en

P1433

Q33360753-38B0E5AD-C617-452B-9C9F-AA9CBB2263E1

P1476

Q33360753-D612389F-E9A4-4111-9966-C96DEC427F61

P2093

Q33360753-01C5F514-2790-491D-8C6A-58D310A41CAB

Q33360753-0C719B2E-001F-40F2-9B2E-AF24D2DB9A40

Q33360753-119BE81C-16E2-415C-A684-D1A578018876

Q33360753-254806D4-D4A6-4829-8615-F1466ABDB758

Q33360753-72C7BAC6-42AD-4B61-95C9-7869DFF66365

Q33360753-74B92A47-276F-409F-BCFC-9F7ED47DBE06

Q33360753-82E85A91-38AB-4374-9F09-CA4E7A720C89

Q33360753-99E0EEFE-FBBC-4772-83C3-7F7826B33CCD

Q33360753-BD3D2865-AA00-4A38-8A53-12EB1C33927B

Q33360753-C43C5B54-929B-495F-92A9-A4769F7AB6C9

P2860

Q33360753-1A0CF0A3-6CF5-4F23-922E-75DBBA105EEC

Q33360753-B601845D-2267-4D99-B6D8-8B562D4D0F84

P304

Q33360753-EEE74B94-E215-4C0D-A7A7-660B58448A02

P31

Q33360753-2F0ED3AF-EA3D-45E8-832D-1B2F17E409FA

P356

Q33360753-70AB8106-D8AC-4046-998C-41410ABB4BF1

P407

Q33360753-E9598D59-D4F5-42BE-AAA8-82257E2FC3B2

P433

Q33360753-9D3CB5A6-6487-405F-8D15-2558975719BD

P478

Q33360753-8374E2EB-309E-4680-A4CB-224CA8D32BD2

P50

Q33360753-5E67327D-BA1E-47E6-89CD-87E051DC73F3

P577

Q33360753-9A74C9F0-379B-4B2A-B078-BBB2DB6A2C44

P5875

Q33360753-C6B80C83-5F32-4A59-861B-9D08C1A2B98A

P698

Q33360753-C14CED79-85BD-45D0-99C5-71545785B675

P921

Q33360753-594138A5-3DB4-4025-844A-AABFFA26D33E

P356

P1433

P1476

Phase II study of temozolomide ...... rme in an elderly populations.

@en

P2093

D Braguer

http://www.w3.org/2001/XMLSchema#string

Elisabeth Frauger

http://www.w3.org/2001/XMLSchema#string

François Grisoli

http://www.w3.org/2001/XMLSchema#string

Henry Dufour

http://www.w3.org/2001/XMLSchema#string

Jacky Palmari

http://www.w3.org/2001/XMLSchema#string

Jean-Claude C Peragut

http://www.w3.org/2001/XMLSchema#string

Karima Moktari

http://www.w3.org/2001/XMLSchema#string

Khe Hoang-Xuan

http://www.w3.org/2001/XMLSchema#string

Maryline Barrie

http://www.w3.org/2001/XMLSchema#string

Olivier-L Chinot

http://www.w3.org/2001/XMLSchema#string

P2860

Malignant supratentorial glioma in the elderly: is radiotherapy useful?

Age influences chemotherapy response in astrocytomas.

P304

2208-2214

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.20224

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Dominique Figarella-Branger

P577

2004-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8567009

http://www.w3.org/2001/XMLSchema#string

P698

15139066

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy